Beta Drugs Ltd share price logo

Beta Drugs Ltd Share Price (BETA)

Check the latest share price of Beta Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹18100.93%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Beta Drugs Ltd Stock Performance

Get live Beta Drugs Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹1,755
    Day's Price Range
    ₹1,816
  • 52 Week's Low

    52 Week's High

    ₹58.96
    52-Week Price Range
    ₹2,215.24
1 Month Return-2.37 %
3 Month Return+ 8.24 %
1 Year Return+ 55.38 %
3 Year Return+ 120.9 %
5 Year Return+ 3551.4 %
Previous Close₹1,793.25
Open₹1,755.00
Volume3,360.00
Upper Circuit₹2,151.90
Lower Circuit₹1,434.60

Beta Drugs Ltd Fundamentals & Key Indicators

Check Beta Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,827.11 Cr

Return on Equity (ROE)

20.67

PE Ratio (TTM)

0

Return on capital employed (ROCE)

26.6

Beta (LTM)

1.42

P/B Ratio

10.22

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

37.9

Sector

Pharmaceuticals

Book Value

163.43

Technical Analysis

How to invest in Beta Drugs Ltd?

Investing in Beta Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Beta Drugs Ltd or BETA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Beta Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Beta Drugs Ltd with just a few clicks!

Beta Drugs Ltd Stock's Interest Amongst Investors

-13%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Beta Drugs Ltd Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Beta Drugs Ltd Financial Results

Get the annual and quarterly financial summary of Beta Drugs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

86 (0%)111 (29%)134 (21%)170 (27%)
Total Liabilities

(in ₹ Cr)

23 (0%)33 (47%)38 (13%)54 (44%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

6 (0%)12 (90%)19 (62%)10 (45%)21 (107%)

Beta Drugs Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Beta Drugs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.73%
0.00
Foreign Institutions
0.9%
0.00
Mutual Funds
0%
0.00
Retail Investors
32.2%
0.00
Others
0.17%
0.00

Beta Drugs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Beta Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA1,827.11710.28%0.5436295
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Beta Drugs Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Beta Drugs Ltd.

  • Beta Drugs Ltd Shows Strong Growth Amid Discounted Trading - 08 Apr, 2025

    Beta Drugs Ltd, specializing in oncology, is trading at a 17% discount from its 52-week high. The company reported a 28% revenue increase and a 20% rise in net profit for H1 FY25, showcasing solid financials and growth potential. With strong domestic and international sales, it remains a key player in the pharmaceutical sector.

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.95% to 32.20% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, BETA stock has moved up by 55.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.73% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 10.2%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.15% to 0.90% in Mar 2025 quarter

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
IndustryPharmaceuticals
CEORahul Batra
E-voting on sharesClick here to vote

FAQs

What is Beta Drugs Ltd share price today?

Beta Drugs Ltd share price today stands at ₹1810, Open: ₹1755, Previous Close: ₹1793.25, High: ₹1816, Low: ₹1755, 52 Week High: ₹2215.24, 52 Week Low: ₹58.96.

What is today's traded volume of Beta Drugs Ltd?

Today's traded volume of Beta Drugs Ltd is 3,360.00. Which means that 3,360.00 shares of Beta Drugs Ltd were bought and sold on the stock market during today's trading session.

What is Beta Drugs Ltd's market cap today?

Today's market capitalisation of Beta Drugs Ltd is ₹1,827.11 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Beta Drugs Ltd?

Beta Drugs Ltd’s 52 week high is ₹2215.24 and 52 week low is ₹58.96. The current share price of Beta Drugs Ltd is ₹1810, which is -18.29% down from its 52 week high and 2969.88% up from its 52 week low.